Rhophilin 2 is a Rho GTPase binding protein initially isolated by differential screening of a chronically thyrotropin (TSH)-stimulated dog thyroid cDNA library. In thyroid cell culture, expression of rhophilin 2 mRNA and protein is enhanced following TSH stimulation of the cyclic AMP (cAMP) transduction cascade. Yeast two-hybrid screening and coimmunoprecipitation have revealed that the GTP-bound form of RhoB and components of the cytoskeleton are protein partners of rhophilin 2. These results led us to suggest that rhophilin 2 could play an important role downstream of RhoB in the control of endocytosis during the thyroid secretory process which follows stimulation of the TSH/cAMP pathway. To validate this hypothesis, we generated rhophilin 2-deficient mice and analyzed their thyroid structure and function. Mice lacking rhophilin 2 develop normally, have normal life spans, and are fertile. They have no visible goiter and no obvious clinical signs of hyper-or hypothyroidism. The morphology of thyroid cells and follicles in these mice were normal, as were the different biological tests performed to investigate thyroid function. Our results indicate that rhophilin 2 does not play an essential role in thyroid physiology.Thyrotropin (TSH) is the main physiological agent regulating the thyroid gland. TSH binds to its specific receptor on the surface of the thyrocyte and activates a G protein-coupled mechanism to stimulate adenylate cyclase, leading to cyclic AMP (cAMP) production. TSH and cAMP promote thyroid cell proliferation, function, and differentiation, while the mitogenic pathway elicited by epidermal growth factor and tumor-promoting phorbol ester are associated with the loss of expression of the differentiation-specific genes (4, 5). Many of the regulatory steps of these pathways have been analyzed by means of an in vitro dog thyroid cell culture model in our laboratory in recent years (13). However, several steps of the TSH-cAMP cascade are still unknown: the molecular mechanisms of this pathway downstream of cAMP, cAMP-dependent protein kinase, and its phosphorylated targets are unclear (3).A study aimed at the identification of genes that are positively or negatively regulated by TSH and cAMP in dog thyroid cells was thus initiated: a cDNA library was prepared from dogs treated in vivo with methimazole and propylthiouracil, two agents known to inhibit thyroid hormone synthesis (17). This inhibition leads to relief of the inhibitory control of these thyroid hormones on the hypophysis and to TSH secretion and chronic TSH stimulation of the thyroid cells. By differential screening of this cDNA library with digoxigenin-labeled cDNA probes derived from quiescent or stimulated thyroid tissues, several new differentially expressed genes were identified. Among these, rhophilin 2 (Rhpn2, previously reported as clone 45, p76 RBE , or Rho binding protein 2) was particularly well analyzed in our laboratory. Rhpn2, whose mRNA and protein expression is enhanced in thyrocytes following TSH stimulation of the cAMP transd...